↓ Skip to main content

The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis

Overview of attention for article published in Frontiers in oncology, May 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
108 Dimensions

Readers on

mendeley
181 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis
Published in
Frontiers in oncology, May 2015
DOI 10.3389/fonc.2015.00108
Pubmed ID
Authors

Xiao-Jian Sun, Na Man, Yurong Tan, Stephen D. Nimer, Lan Wang

Abstract

Histone, and non-histone, protein acetylation plays an important role in a variety of cellular events, including the normal and abnormal development of blood cells, by changing the epigenetic status of chromatin and regulating non-histone protein function. Histone acetyltransferases (HATs), which are the enzymes responsible for histone and non-histone protein acetylation, contain p300/CBP, MYST, and GNAT family members. HATs are not only protein modifiers and epigenetic factors but also critical regulators of cell development and carcinogenesis. Here, we will review the function of HATs such as p300/CBP, Tip60, MOZ/MORF, and GCN5/PCAF in normal hematopoiesis and the pathogenesis of hematological malignancies. The inhibitors that have been developed to target HATs will also be reviewed here. Understanding the roles of HATs in normal/malignant hematopoiesis will provide the potential therapeutic targets for the hematological malignancies.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 181 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 55 30%
Student > Bachelor 23 13%
Student > Master 19 10%
Researcher 15 8%
Student > Doctoral Student 8 4%
Other 19 10%
Unknown 42 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 68 38%
Agricultural and Biological Sciences 27 15%
Chemistry 9 5%
Medicine and Dentistry 7 4%
Immunology and Microbiology 6 3%
Other 17 9%
Unknown 47 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2023.
All research outputs
#6,659,232
of 26,369,714 outputs
Outputs from Frontiers in oncology
#2,195
of 23,018 outputs
Outputs of similar age
#70,026
of 281,467 outputs
Outputs of similar age from Frontiers in oncology
#11
of 69 outputs
Altmetric has tracked 26,369,714 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 23,018 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 281,467 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.